Mortality Indicatora | Early stage (August 2011–July 2013) | |||
---|---|---|---|---|
CHW without Medicines | CHW with Medicines | |||
HRb (95% CI) | P-valuec | HR (95% CI) | P-value | |
Neonatal mortality (0-28 days) | 1·03 (0·72–1·48) | 0·860 | 1·11 (0·88–1·41) | 0·385 |
Post-Neonatal mortality (1-59 months) | 0·85 (0·68–1·04) | 0·115 | 0·85 (0·75–0·96) | 0·012 |
Under-5 mortality (0-59 months) | 0·90 (0·73–1·11) | 0·329 | 0·93 (0·83–1·04) | 0·181 |
Late stage (August 2013–June 2015) | ||||
Neonatal mortality (0-28 days) | 0·89 (0·59–1·33) | 0·562 | 1·01 (0·75–1·34) | 0·957 |
Post-Neonatal mortality (1-59 months) | 1·42 (1·07–1·88) | 0·015 | 0·95 (0·79–1·14) | 0·589 |
Under-5 mortality (0-59 months) | 1·21 (0·95–1·55) | 1·125 | 0·97 (0·82–1·16) | 0·763 |
Overall (August 2011–June 2015) | ||||
Neonatal mortality (0-28 days) | 0·98 (0·73–1·31) | 0·898 | 1·06 (0·85–1·32) | 0·592 |
Post-Neonatal mortality (1-59 months) | 1·01 (0·82–1·24) | 0·933 | 0·90 (0·80–1·00) | 0·054 |
Under-5 mortality (0-59 months) | 0·99 (0·85–1·18) | 0·979 | 0·95 (0·84–1·07) | 0·384 |